Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

Cited by (1,001)

Items 601–700 of 1,001

1. Recent advances in HIV-associated Kaposi sarcoma
   Alessia Dalla Pria, David James Pinato, Margherita Bracchi, Mark Bower · 2019 · F1000Research
2. CD57+ Memory T Cells Proliferate In Vivo
   Raya Ahmed, Kelly L. Miners, Julio Lahoz-Beneytez, Rhiannon E. Jones, Lauréline Roger, CHRISTINA BABOONIAN, Yan Zhang, Eddie C. Y. Wang, Marc K. Hellerstein, J M McCune et al. · 2020 · Cell Reports
3. Reversal of functional defects in highly differentiated young and old CD8 T cells by PDL blockade
   Henson, Sian M., Macaulay, Richard, Franzese, Ornella, Akbar, Arne N. · 2012 · Immunology
4. New therapeutic vaccination strategies for the treatment of chronic hepatitis B
   Jia Liu, Anna D. Kosinska, Mengji Lu, Michael Roggendorf · 2014 · Virologica Sinica
5. Natural Suppression of Human Immunodeficiency Virus Type 1 Replication Is Mediated by Transitional Memory CD8+T Cells
   M. Scott Killian, Carl Johnson, Fernando Teque, Sue H. Fujimura, Jay A. Levy · 2010 · Journal of Virology
6. Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity
   Emily Marie Eriksson, Jeffrey M. Milush, Emily L. Ho, Mariana Dias Batista, Sara J. Holditch, Chris E. Keh, Philip J. Norris, Sheila Marie Keating, Steven G. Deeks, Peter W. Hunt et al. · 2011 · Blood
7. Innate and Adaptive Immune Responses Both Contribute to Pathological CD4 T Cell Activation in HIV-1 Infected Ugandans
   Michael A. Eller, Kim G. Blom, Veronica D. Gonzalez, Leigh Anne Eller, Prossy Naluyima, Oliver B Laeyendecker, Thomas C. Quinn, Noah Kiwanuka, David Serwadda, Nelson Kaulukusi Sewankambo et al. · 2011 · PLoS ONE
8. PD-1 and PD-L1 Inhibitors in Melanoma Treatment: Past Success, Present Application and Future Challenges
   Jenny Lee, Richard F. Kefford, Matteo Salvatore Carlino · 2016 · Immunotherapy
9. Nivolumab Treatment for Cancers in the HIV-infected Population
   Elaine Chang, Anita Lyn Sabichi, Jennifer R. Kramer, Christine M. Hartman, Kathryn E. Royse, Donna L. White, Niraj R. Patel, Peter Richardson, Sarvari Venkata Yellapragada, José M. Garcia et al. · 2018 · Journal of Immunotherapy
10. An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression
    Federico Perdomo-Celis, Paula A. Velilla, Natalia A. Taborda, Marı́a Teresa Rugeles · 2019 · PLoS ONE
11. Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy
    Mohamed Labib Salem · 2015 · World Journal of Hepatology
12. Phenotype and function of protective T cell immune responses in HIV
    Michael R. Betts, Alexandre Harari · 2008 · Current Opinion in HIV and AIDS
13. Influenza-Specific T Cells from Older People Are Enriched in the Late Effector Subset and Their Presence Inversely Correlates with Vaccine Response
    Lisa E. Wagar, Beth Gentleman, Hanspeter Pircher, Janet E. McElhaney, Tania H. Watts · 2011 · PLoS ONE
14. Activation drives PD‐1 expression during vaccine‐specific proliferation and following lentiviral infection in macaques
    David A. Hokey, F Brad Johnson, Jasmine S. Smith, J Weber, Jian Yan, Lauren A. Hirao, Jean Boyer, Mark G. Lewis, George Makedonas, Michael R. Betts et al. · 2008 · European Journal of Immunology
15. Erratum: Corrigendum: Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
    Lydie Trautmann, Loury Janbazian, Nicolas Chomont, Elias Anthony Said, Sylvain Gimmig, Benoit Bessette, MR Boulassel, Eric Delwart, Homero Sepulveda, ROBERT S. BALDERAS et al. · 2006 · Nature Medicine
16. Promise and Challenges of T Cell Immunotherapy for Osteosarcoma
    Jeong Ah Park, Nai‐Kong V. Cheung · 2023 · International Journal of Molecular Sciences
17. The immunological synapse: the gateway to the HIV reservoir
    Deanna A. Kulpa, Jessica H. Brehm, Rémi Fromentin, Anthony B. Cooper, Colleen Cooper, Jeffrey D. Ahlers, Nicolas Chomont, Rafick‐Pierre Sékaly · 2013 · Immunological Reviews
18. Upregulation of TIM-3 and PD-1 on CD4+ and CD8+ T Cells Associated with Dysfunction of Cell-Mediated Immunity after Colorectal Cancer Operation.
    Yosuke Arai, Hiroaki Saito, Masahide Ikeguchi · 2012 · Europe PMC (PubMed Central)
19. PD-1 function in apoptosis of T lymphocytes in canine visceral leishmaniasis
    Vanessa Marim Chiku, Kathlenn Liezbeth Oliveira Silva, Breno Fernando Martins de Almeida, Gabriela Lovizutto Venturin, Aline Aparecida Correa Leal, Cleber Costa de Martini, Flávia de Rezende Eugênio, Paulo Sérgio Patto dos Santos, Valéria Marçal Felix de Lima · 2016 · Immunobiology
20. Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer
    Kathryn Anne Lurain, Ramya Ramaswami, Robert Yarchoan, Thomas S. Uldrick · 2020 · Current HIV/AIDS Reports
21. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+T-Cell Population in Elite Controllers
    Carolina Pombo, E. John Wherry, Emma Gostick D, David A. Price, Michael R. Betts · 2015 · The Journal of Infectious Diseases
22. Immune Exhaustion: Past Lessons and New Insights from Lymphocytic Choriomeningitis Virus
    Shannon M. Kahan, Allan J Zajac · 2019 · Viruses
23. Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers
    Pablo Tebas, Sergei V. Spitsin, Jeffrey S. Barrett, Florin Tuluc, Okan Umit Elci, James Korelitz, Wayne Wagner, Angela Winters, Deborah Kim, Renae Catalano et al. · 2015 · AIDS
24. Clonotype and Repertoire Changes Drive the Functional Improvement of HIV-Specific CD8 T Cell Populations under Conditions of Limited Antigenic Stimulation
    Loury Janbazian, David A. Price, Glenda Canderan, Abdelali Filali-Mouhim, Tedi E. Asher, David R. Ambrozak, Phillip Scheinberg, Mohamad Rachid Boulassel, Jean‐Pierre Routy, Richard A. Koup et al. · 2011 · The Journal of Immunology
25. The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection
    Vikram Mehraj, Mohammad-Ali Jenabian, Rosalie Ponte, Bertrand Lebouché, Cecilia Theresa Costiniuk, Réjean Thomas, Jean-Guy Baril, Roger P. LeBlanc, Joseph Cox, Cecile L. Tremblay et al. · 2016 · AIDS
26. Acute Traumatic Brain Injury Induces CD4+ and CD8+ T Cell Functional Impairment by Upregulating the Expression of PD-1 via the Activated Sympathetic Nervous System
    Yongxiang Yang, Yuqin Ye, Chen Chen, Chuiguang Kong, Xinhong Su, Xin Zhang, Wei Bai, Xiaosheng He · 2019 · NeuroImmunoModulation
27. Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?
    Baptiste Abbar, Marine Baron, Christine Katlama, Anne‐Geneviève Marcelin, Marianne Veyri, Brigitte Autran, Amélie Guihot, Jean‐Philippe Spano · 2019 · AIDS
28. Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control
    Federico Perdomo-Celis, Caroline Passaes, Valérie Monceaux, Stevenn Volant, Faroudy Boufassa, Pierre de Truchis, Morgane Marcou, Katia Bourdic, Laurence Weiss, Corinne Jung et al. · 2022 · Journal of Clinical Investigation
29. Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells
    Hiroshi Takata, Juyeon C. Kakazu, Julie L. Mitchell, Eugene D. M. B. Kroon, Donn J. Colby, Carlo Sacdalan, Hongjun Bai, Philip K. Ehrenberg, Aviva Geretz, Supranee Buranapraditkun et al. · 2022 · EBioMedicine
30. Host CCL3L1 Gene Copy Number in Relation to HIV-1-Specific CD4+ and CD8+ T-Cell Responses and Viral Load in South African Women
    Sharon Shalekoff, Stephen Meddows‐Taylor, Diana B. Schramm, Samantha L. Donninger, Glenda Gray, Gayle Gillian Sherman, Ashraf Hassen Coovadia, Louise Kuhn, Caroline T. Tiemessen · 2008 · JAIDS Journal of Acquired Immune Deficiency Syndromes
31. Chronic Activation of the Kinase IKKβ Impairs T Cell Function and Survival
    Sruti Krishna, Danli Xie, Balachandra K. Gorentla, Jinwook Shin, Jimin Gao, Xiao‐Ping Zhong · 2012 · The Journal of Immunology
32. HIV-Mediated Phosphatidylinositol 3-Kinase/Serine–Threonine Kinase Activation in APCs Leads to Programmed Death-1 Ligand Upregulation and Suppression of HIV-Specific CD8 T Cells
    Kar Muthumani, Devon J. Shedlock, Daniel K. Choo, Paolo Fagone, Omkar Uday Kawalekar, Jonathan Goodman, Chaoran B. Bian, Aarti A. Ramanathan, Parikh Atman, Pablo Tebas et al. · 2011 · The Journal of Immunology
33. The Antiviral CD8+ T Cell Response Is Differentially Dependent on CD4+ T Cell Help Over the Course of Persistent Infection
    Christopher C. Kemball, Christopher D. Pack, Heath Guay, Zhu-Nan Li, David A. Steinhauer, Eva Szomolanyi‐Tsuda, Aron E. Lukacher · 2007 · The Journal of Immunology
34. Cryopreservation Decreases Receptor PD-1 and Ligand PD-L1 Coinhibitory Expression on Peripheral Blood Mononuclear Cell-Derived T Cells and Monocytes
    D. E. Campbell, Nancy B. Tustin, Eric Riedel, R. Tustin, Joseph G Taylor, Jennifer B. Murray, Steven D. Douglas · 2009 · Clinical and Vaccine Immunology
35. Dynamic CD8+ T Cell Cooperation with Macrophages and Monocytes for Successful Cancer Immunotherapy
    Anaïs Vermare, Marion V. Guérin, Elisa Peranzoni, Nadège Bercovici · 2022 · Cancers
36. The sound of silence: modulating anergy in T lymphocytes
    Samuel David Saibil, Elissa K. Deenick, Pamela S. Ohashi · 2007 · Current Opinion in Immunology
37. HIV‐1 impairs in vitro priming of naïve T cells and gives rise to contact‐dependent suppressor T cells
    Karlhans F. Che, Rachel Lubong Sabado, Esaki Muthu Shankar, Veronica Tjomsland, Davorka Messmer, Nina Bhardwaj, Jeffrey D. Lifson, Marie Larsson · 2010 · European Journal of Immunology
38. Enhanced Antiviral T Cell Function in the Absence of B7-H1 Is Insufficient To Prevent Persistence but Exacerbates Axonal Bystander Damage during Viral Encephalomyelitis
    Timothy W. Phares, Stephen A. Stohlman, David R. Hinton, Roscoe Atkinson, Cornelia C. Bergmann · 2010 · The Journal of Immunology
39. T-cell therapies for HIV: Preclinical successes and current clinical strategies
    Shabnum Patel, Richard Brad Jones, Douglas F. Nixon, Catherine M. Bollard · 2016 · Cytotherapy
40. Functional role of mucosal-associated invariant T cells in HIV infection
    Alireza Saeidi, Rada Ellegård, Yean Kong Yong, Hong Yien Tan, Vijayakumar Velu, James E. Ussher, Marie Larsson, Esaki Muthu Shankar · 2016 · Journal of Leukocyte Biology
41. Therapeutic vaccines and immunological intervention in HIV infection
    Giuseppe Pantaleo, Yves Lévy · 2016 · Current Opinion in HIV and AIDS
42. Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging
    Anna C. Belkina, Alina Starchenko, Katherine Drake, Elizabeth A. Proctor, Riley M.F. Pihl, Alex Olson, Douglas A. Lauffenburger, Nina Lin, Jennifer E Snyder-Cappione · 2018 · Frontiers in Immunology
43. Transcriptional and epigenetic regulation of PD-1 expression
    Zengde Chi, Yan Lü, Yinlong Yang, Bingqing Li, Peiyuan Lu · 2021 · Cellular and Molecular Life Sciences
44. HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients
    Man Li, Xuehua Sun, Xiaojun Zhu, Shu-Gen Jin, Zhen-Jun Zeng, Zhenhua Zhou, Zhuo Yu, Yueqiu Gao · 2011 · Laboratory Investigation
45. Intranasal but not intravenous delivery of the adjuvant α‐galactosylceramide permits repeated stimulation of natural killer T cells in the lung
    Amy N. Courtney, Prakash Thapa, Shailbala Singh, Ameerah M. Wishahy, Dapeng Zhou, K. Jagannadha Sastry · 2011 · European Journal of Immunology
46. Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells
    Elena Muraro, Anna Merlo, Debora Martorelli, Michela Cangemi, Silvia Dalla Santa, Riccardo Dolcetti, Antonio Rosato · 2017 · Frontiers in Immunology
47. In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection
    Asami Nishimori, Satoru Konnai, Tomohiro Okagawa, Naoya Maekawa, Ryoyo Ikebuchi, Shinya Goto, Yamato Sajiki, Yasuhiko Suzuki, Junko Kohara, Satoshi Ogasawara et al. · 2017 · PLoS ONE
48. B Cell Responses to HIV Antigen Are a Potent Correlate of Viremia in HIV-1 Infection and Improve with PD-1 Blockade
    Katherine J. Nicholas, Emily K. Zern, Louise D. Barnett, Rita M. Smith, Shelly L. Lorey, Courtney A. Copeland, Shanmugalakshmi Sadagopal, Spyros A. Kalams · 2013 · PLoS ONE
49. Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs
    Fatoumata Ba Sow, Jack M. Gallup, Subramaniam Krishnan, Andriani C. Patera, JoAnn Suzich, Mark R. Ackermann · 2011 · Respiratory Research
50. Clinical applications of PD-1-based therapy: a focus on pembrolizumab (MK-3475) in the management of melanoma and other tumor types
    April K.S. Salama, Tara C. Gangadhar · 2015 · OncoTargets and Therapy
51. T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy
    Bernard J. C. Macatangay, Rajesh Tim Gandhi, Richard Brad Jones, Deborah K. McMahon, Christina M. Lalama, Ronald J. Bosch, Joshua C. Cyktor, Allison S. Thomas, Luann Borowski, Sharon A. Riddler et al. · 2019 · AIDS
52. Immune Checkpoint Inhibitors in People Living with HIV/AIDS: Facts and Controversies
    Valeria Castelli, Andrea Lombardi, Emanuele Palomba, Giorgio Bozzi, Riccardo Ungaro, Laura Alagna, Davide Mangioni, Antonio Muscatello, Alessandra Bandera, Andrea Gori · 2021 · Cells
53. Memory CD4+ T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency
    Thomas A. Rasmussen, Jennifer M. Zerbato, Ajantha Rhodes, Carolin Tumpach, Ashanti Dantanarayana, James H. McMahon, Jillian S. Y. Lau, J. Judy Chang, Céline Gubser, Wendy Brown et al. · 2022 · Cell Reports Medicine
54. Cellular Senescence in Immunity against Infections
    Veronica Marrella, Amanda Facoetti, Barbara Cassani · 2022 · International Journal of Molecular Sciences
55. Epithelial adhesion molecules can inhibit HIV-1–specific CD8+ T-cell functions
    Hendrik Streeck, Douglas S. Kwon, Augustine Pyo, Michael Flanders, Mathieu F. Chevalier, Kenneth Law, Boris Dominik Jülg, Kasper Trocha, Jonathan S. Jolin, Melis N. Anahtar et al. · 2011 · Blood
56. Increased Programmed Death-1 Molecule Expression in Cytomegalovirus Disease and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
    Ghislaine M. Gallez-Hawkins, Lia Thao, Joycelynne Michelle Palmer, Andrew Dagis, Xiuli Li, Anne E. Franck, Bernard Tegtmeier, Simon Francis Lacey, Don J. Diamond, Stephen J. Forman et al. · 2009 · Transplantation and Cellular Therapy
57. Efficient Nef-Mediated Downmodulation of TCR-CD3 and CD28 Is Associated with High CD4 + T Cell Counts in Viremic HIV-2 Infection
    Mohammad Khalid, Hangxing Yu, Daniel Sauter, Shariq M. Usmani, Jan Schmökel, Jerome Feldman, Rob A. Gruters, Marchina E. van der Ende, Matthias Geyer, Sarah Rowland‐Jones et al. · 2012 · Journal of Virology
58. Simian Immunodeficiency Virus (SIV)-Specific CD8+T-Cell Responses in Vervet African Green Monkeys Chronically Infected with SIVagm
    Roland C. Zahn, Melisa D. Rett, Birgit Korioth-Schmitz, Yue Sun, Adam P. Buzby, Simoy C. Goldstein, Charles R. Brown, Russell A. Byrum, Gordon James Freeman, Norman L. Letvin et al. · 2008 · Journal of Virology
59. A Nonprogressive Clinical Course in HIV‐Infected Individuals Expressing Human Leukocyte Antigen B57/5801 Is Associated with Preserved CD8+T Lymphocyte Responsiveness to the HW9 Epitope in Nef
    Marjon Navis, Ingrid M. M. Schellens, Peter van Swieten, José A. M. Borghans, Frank F. Miedema, Neeltje A. Kootstra, Debbie van Baarle, Hanneke Schuitemaker · 2008 · The Journal of Infectious Diseases
60. Memory Generation and Maintenance of CD8+ T Cell Function during Viral Persistence
    Stephanie S. Cush, Kathleen M Anderson, David H. Ravneberg, Janet L. Weslow-Schmidt, Emilio Flaño · 2007 · The Journal of Immunology
61. CRISPR/Cas9-mediated deletion of miR-146a enhances antiviral response in HIV-1 infected cells
    Yan Teng, Mingqi Luo, Ting Yu, Lang Chen, Qiuling Huang, Shuliang Chen, Linlin Xie, Yan Zeng, Luo Fan, Hairong Xiong et al. · 2018 · Genes and Immunity
62. Functional Restoration of Exhausted CD8 T Cells in Chronic HIV-1 Infection by Targeting Mitochondrial Dysfunction
    Aljawharah Alrubayyi, Elia Moreno Cubero, Dan Hameiri‐Bowen, Rebecca Matthews, Sarah Rowland‐Jones, Anna Schurich, Dimitra Peppa · 2022 · Frontiers in Immunology
63. Regulation of T cell exhaustion and stemness: molecular mechanisms and implications for cancer immunotherapy
    Zeyu Chen, Ziang Zhu, Taidou Hu, Chen Yao, Tuoqi Wu · 2025 · Cellular and Molecular Immunology
64. PD-L1/B7-H1 Regulates the Survival but Not the Function of CD8+ T Cells in Herpes Simplex Virus Type 1 Latently Infected Trigeminal Ganglia
    Sohyun Jeon, Anthony J. St. Leger, Thomas L. Cherpes, Brian S. Sheridan, Robert L. Hendricks · 2013 · The Journal of Immunology
65. Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa
    Yi‐Chen Chen, Qiusheng Li, Xinye Li, Da Ma, Juan Fang, Liqun Luo, Xiangqi Liu, Xi Wang, Vivian Wai Yan Lui, Juan Xia et al. · 2017 · OncoImmunology
66. PD-1 Expression during Acute Infection Is Repressed through an LSD1–Blimp-1 Axis
    Alexander P. R. Bally, Dennis Kyle Neeld, Peiyuan Lu, Parimal Majumder, Yan Tang, Benjamin G. Barwick, Qing Wang, Jeremy M. Boss · 2019 · The Journal of Immunology
67. CD8+ regulatory T cells in persistent human viral infections
    Eva Billerbeck, Robert Thimme · 2008 · Human Immunology
68. Effect of dietary nucleotides on immune function in Balb/C mice
    Meihong Xu, Ming Zhao, Ruiyue Yang, Zhaofeng Zhang, Yong Li, Junbo Wang · 2013 · International Immunopharmacology
69. Distinct SIV-specific CD8+ T cells in the lymph node exhibit simultaneous effector and stem-like profiles and are associated with limited SIV persistence
    Zachary Strongin, Laurence Raymond Marchand, Claire Deléage, María Betina Pampena, Maria Andrea Cardenas, Christian Michel Beusch, Timothy N. Hoang, Elizabeth Urban, Maël Gourvès, Kevin Nguyen et al. · 2024 · Nature Immunology
70. Immune checkpoint inhibitors in infectious disease
    Hannah A. D. King, Sharon R. Lewin · 2024 · Immunological Reviews
71. The characteristic profiles of PD-1 and PD-L1 expressions and dynamic changes during treatment in active tuberculosis
    Lei Shen, Hong Shi, Yan Gao, Qinfang Ou, Qianqian Liu, Yuanyuan Liu, Jing Wu, Wenhong Zhang, Lin Fan, Lingyun Shao · 2016 · Tuberculosis
72. Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice
    Thomas D. Norton, Anjie Zhen, Takuya Tada, Jennifer S. Kim, Scott G. Kitchen, Nathaniel Roy Landau · 2019 · Molecular Therapy
73. Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies
    Aurélie Delannoy, Mikaël Poirier, Brendan Bell · 2019 · Viruses
74. Tumor suppression of novel anti–PD-1 antibodies mediated through CD28 costimulatory pathway
    Craig W. Fenwick, Juan-Luis Loredo-Varela, Victor Joo, Céline Pellaton, Alex Farina, Navina Rajah, Line Esteves-Leuenberger, Thibaut Decaillon, Madeleine Suffiotti, Alessandra Noto et al. · 2019 · The Journal of Experimental Medicine
75. The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy
    Jillian S. Y. Lau, James H. McMahon, Céline Gubser, Ajantha E. Solomon, Chris Y. H. Chiu, Ashanti Dantanarayana, Socheata Chea, Surekha Tennakoon, Jennifer M. Zerbato, Jill S. Garlick et al. · 2021 · AIDS
76. Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection
    Nader Yatim, Jérémy Boussier, Pauline Tétu, Nikaïa Smith, Timothée Bruel, Bruno Charbit, Laura Barnabei, Aurélien Corneau, Laetitia Da Meda, Clara Allayous et al. · 2021 · Science Advances
77. The Status of Adjuvant and Neoadjuvant Melanoma Therapy, New Developments and Upcoming Challenges
    Henner M. Stege, Maximilian Haist, Ulrike Nikfarjam, Michael Schultheis, Jaqueline Heinz, Saskia Pemler, Carmen Loquai, Stephan Grabbe · 2021 · Targeted Oncology
78. B and T Lymphocyte Attenuator Down-regulation by HIV-1 Depends on Type I Interferon and Contributes to T-Cell Hyperactivation
    Zhang, Zheng, Xu, Xiangsheng, Lu, Jiyun, Zhang, Shuye, Gu, Lanlan, Fu, Junliang, Jin, Lei, Li, Haiying, Zhao, Min, Zhang, Jiyuan et al. · 2011 · The Journal of Infectious Diseases
79. TLR-mediated induction of negative regulatory ligands on dendritic cells
    Stefan Gröschel, Kisha Piggott, Augusto Vaglio, Wei Ma-Krupa, Karnail Singh, Jörg J. Goronzy, Cornelia M. Weyand · 2008 · Journal of Molecular Medicine
80. Inflammatory and Immune Mechanisms for Atherosclerotic Cardiovascular Disease in HIV
    Laura Hmiel, Suyu Zhang, Laventa M. Obare, Marcela Araújo de Oliveira Santana, Celestine N. Wanjalla, Boghuma Kabisen Titanji, Corrilynn O. Hileman, Shashwatee Bagchi · 2024 · International Journal of Molecular Sciences
81. 5th International Workshop on CMV and Immunosenescence ‐ A shadow of cytomegalovirus infection on immunological memory
    Ramon Arens, Ester B. M. Remmerswaal, Jos A. Bosch, René A. W. van Lier · 2015 · European Journal of Immunology
82. Expression levels of CD28, CTLA-4, PD-1 and Tim-3 as novel indicators of T-cell immune function in patients with chronic hepatitis B virus infection
    Lin Wang, Chunnan Zhao, Qunxin Peng, Jinfang Shi, Guohao Gu · 2014 · Biomedical Reports
83. Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated with Increased PD-1 Expression on Effector CD8+ T Cells
    Mohamed Elrefaei, Chris A. R. Baker, Norman G. Jones, David R. Bangsberg, Huyen Cao · 2008 · The Journal of Immunology
84. Impact of changes in antigen level on CD38/PD‐1 co‐expression on HIV‐specific CD8 T cells in chronic, untreated HIV‐1 infection
    Thomas Vollbrecht, Heike Brackmann, Nadja Henrich, Joerg Roeling, Ulrich Seybold, Johannes Richard Bogner, Frank Detlef Goebel, Rika Draenert · 2010 · Journal of Medical Virology
85. Suboptimal Immune Reconstitution in Vertically HIV Infected Children: A View on How HIV Replication and Timing of HAART Initiation Can Impact on T and B-cell Compartment
    Nicola Cotugno, Iyadh Douagi, Paolo Rossi, Paolo Palma · 2012 · Clinical and Developmental Immunology
86. Altering Effects of Antigenic Variations in HIV-1 on Antiviral Effectiveness of HIV-Specific CTLs
    Takamasa Ueno, Yuka Idegami, Chihiro Motozono, Shinichi Oka, Masafumi Takiguchi · 2007 · The Journal of Immunology
87. Do regulatory T-cells play a role in AIDS pathogenesis?
    Adriano Boasso, Monica Vaccari, Jakob Nilsson, Shearer Gm, Jan Andersson, Valentina Cecchinato, Claire Anne Chougnet, Genoveffa Franchini · 2006 · PubMed
88. Transcription factor BACH2 shapes tissue-resident memory T cell programs to promote HIV-1 persistence
    Yulong Wei, Haocong Katherine Ma, Michelle E. Wong, Hyein Back, Emmanouil Papasavvas, Karam Mounzer, Faten N. Aberra, Ricardo Morgenstern, Pablo Tebas, Liza Konnikova et al. · 2025 · Immunity
89. Lymph node architecture collapse and consequent modulation of FOXO3a pathway on memory T- and B-cells during HIV infection
    Julien van Grevenynghe, Rabih Halwani, Nicolas Chomont, Petronela Ancuța, Yoav Peretz, André Tanel, Francesco A. Procopio, Yu shi, Elias Anthony Said, Elias K. Haddad et al. · 2008 · Seminars in Immunology
90. PD-1/PD-L1 Blockade Can Enhance HIV-1 Gag-specific T Cell Immunity Elicited by Dendritic Cell-Directed Lentiviral Vaccines
    Bingbing Dai, Xiao Liang, Paul D. Bryson, Jinxu Fang, Pin Wang · 2012 · Molecular Therapy
91. Immune-surveillance through exhausted effector T-cells
    Dietmar Zehn, Daniel T. Utzschneider, Robert Thimme · 2016 · Current Opinion in Virology
92. DDX3 in HIV-1 infection and sensing: A paradox
    Melissa Stunnenberg, Teunis B. H. Geijtenbeek, Sonja I. Gringhuis · 2018 · Cytokine & Growth Factor Reviews
93. Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
    Genevieve Clutton, Richard Brad Jones · 2018 · Frontiers in Immunology
94. Low levels of SIV-specific CD8+ T cells in germinal centers characterizes acute SIV infection
    Shengbin Li, Joy M. Folkvord, Katalin J. Kovács, Reece K. Wagstaff, Gwantwa Mwakalundwa, Aaron Rendahl, Eva G. Rakasz, Elizabeth Connick, Pamela J. Skinner · 2019 · PLoS Pathogens
95. The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?
    Hui Chen, Maha Moussa, Marta Catálfamo · 2020 · Frontiers in Immunology
96. Optimal Maturation of the SIV-Specific CD8+ T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC Study
    Caroline Passaes, Antoine Millet, Vincent Madelain, Valérie Monceaux, Annie David, Pierre Versmisse, Naya Sylla, Emma Gostick D, Sian Llewellyn‐Lacey, David A. Price et al. · 2020 · Cell Reports
97. Probing the Interface of HIV and Inflammaging
    Scott F. Sieg, Carey L. Shive, Soumya Panigrahi, Michael L. Freeman · 2021 · Current HIV/AIDS Reports
98. Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
    Gabriele Roccuzzo, Silvia Giordano, Paolo Fava, Alessandro Pileri, Alba Guglielmo, Luca Tonella, Martina Sanlorenzo, Simone Ribero, Maria Teresa Fierro, Pietro Quaglino · 2021 · Frontiers in Oncology
99. HTLV-1 Tax Specific CD8+ T Cells Express Low Levels of Tim-3 in HTLV-1 Infection: Implications for Progression to Neurological Complications
    Lishomwa C. Ndhlovu, Fábio E. Leal, Aaron M. Hasenkrug, Aashish R. Jha, Karina Inacio Carvalho, Ijeoma G. Eccles-James, Fernanda Romano Bruno, Raphaella G. S. Vieira, Vanessa A. York, Glen M. Chew et al. · 2011 · PLoS neglected tropical diseases
100. Dominant Clonotypes within HIV-Specific T Cell Responses Are Programmed Death-1high and CD127low and Display Reduced Variant Cross-Reactivity
     Joseph A. Conrad, Ramesh K. Ramalingam, Rita M. Smith, Louise D. Barnett, Shelly L. Lorey, Jie Wei, Brenna C. Simons, Shanmugalakshmi Sadagopal, Dirk Meyer‐Olson, Spyros A. Kalams · 2011 · The Journal of Immunology